ORIGINAL RESEARCH
Published on 17 Feb 2026
Identification of predictive biomarkers and dose optimization for camrelizumab combined with apatinib in the treatment of advanced hepatocellular carcinoma: a quantitative systems pharmacology approach
doi 10.3389/fimmu.2026.1617227
- 178 views




